In summary, these findings suggest that MRPL12 K163 acetylation is a crucial factor in ccRCC tumorigenesis and progression, as demonstrated by both in vitro and in vivo studies. This evidence concerns the gene MRPL12 and nonpapillary renal cell carcinoma.